In vitro and in vivo Growth Inhibition of SC-M1 Gastric Cancer Cells by Retinoic Acid

Oncology (Switzerland)

Volumn 53, Issue 4, 1996, Pages 334-340

  Jiang, Shun Yuan ^a,b   Shyu, Rong Yaun ^a,d   Chen, Hour Young ^e   Lee, May Meei Shyuan ^c   Wu, Kuo Liang ^d   Yeh, Ming Yang ^b  

^a Graduate Institute of Medical Sciences   (China)

^b Department of Microbiology and Immunology ^*  (China)

^c National Defense Medical Center   (China)

^d Tri Service General Hospital   (China)

^e Institute of Preventive Medicine   (China)

Author keywords

Athymic nude mice; Gastric cancer cells; Growth regulation; Retinoic acid

Indexed keywords

CELL DNA; RETINOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CIS ISOMER; CONTROLLED STUDY; DRUG EFFECT; DRUG IMPLANT; DRUG POTENCY; FEMALE; FRACTURE; HUMAN; HUMAN CELL; ISOMER; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; STOMACH CANCER; STRUCTURE ACTIVITY RELATION; SUSTAINED RELEASE PREPARATION; TRANS ISOMER; TUMOR GROWTH; WEIGHT REDUCTION;

ANIMALS; CELL CYCLE; CELL DIVISION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; HUMANS; MICE; MICE, NUDE; STOMACH NEOPLASMS; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0029885910     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227583     Document Type: Article

References (41)

1. Smith MA, Parkison DR, Cheson BD, Friedman MA: Retinoids in cancer therapy, J Clin Oncol 1992;10:839-864.
2. Lippman SM, Kessler JF, Mcvsken FL Jr: Ret i-noids as preventative and therapeutic anticancer agents (part I), Cancer Treat Rep 1987:71: 391-405.
3. Lippman SM, Parkinson DR, Itri LM, Weber RS, Schanlz SP, Ota DM, Schusterman MA, Krakoff IH, Gutterman JU, Hong WK: 13-cis Retinoic acid and interferon alpha-2a: Effec-tive combination therapy for advanced squamous cell carcinoma of the skin, J Natl Cancer Inst 1992:84:235-241.
4. Giguere V: Retinoic acid receptors and cellular retinoid binding proteins: Complex interplay in retinoid signaling, Endocrinol Rev 1994:15: 61-79.
5. Bailly J, Delescluse C, Bernardon JM, Charpentier B, Martin B, Pilgrim WR, Shroot B, Darmon M: Differentiation of F9 embryonal carcinoma cells by synthetic retinoids: Amplitude of plasminogen activator production docs not depend on retinoids potency or affinity for F9 nuclear retinoic acid receptors, Skin Pharmacol 1990;3:256-267.
6. Grettaz M, Baron A, Sicgcnthalcr G, Hunziker W: Ligand specificities of recombinant retinoic acid receptors RAR alpha and RAR beta, Bio-chem J 1990:272:391-397.
7. Astrom A, Pettersson U, Krust A, Chambon P, Voorhecs JJ: Retinoic acid and synthetic analogs differentially activ ate retinoic acid receptor dependent transcription, Boehem Biophys ResCommun 1990:173:339-345.
8. Teclmann K, Tsukaguchi T, Klaus M, Eliason JF: Comparison of the therapeutic effects of a new carotinoid, Ro 40-8757. and all-trans- and 13-cis-rctinoic acids on rat breast cancer, Cancer Res 1993:53:2319-2325.
9. Wetherall NT, Mitchell WM, Halter SA: Antiproliferative elTcct of vitamin A on xenotrans-planted CaMa-15 cells, Cancer Res 1984:44: 2393-2397.
10. Halter SA, Fraker LD, Adcock D, Vick S: ElTcct of retinoids on xcnotransplanted human mammary carcinoma cells in athymic mice, Cancer Res 1988:48:3733-3736.
11. Chauvent FH, Paque RE: Effect of all-trans rctinoic acid on induction, lethality and immu-nogcnicity of murine mcthylcholanthrene-in-duced fibrosarcomas, Int J Cancer 1982:30: 187-192.
12. Dillehay DL, Shealy YF, Lamon EW: Inhibition of Moloney murine lymphoma and sarcoma growth in vivo by dietary retinoids, Cancer Res 1989:49:44-50.
13. Abemavor E: The effects of retinoic acid on the in vitro and in vivo growth of neuroblastoma cells, Laryngoscope 1992:102:1133-1149.
14. Felix E, Loyd B, Cohen MH: Inhibition of the growth and development of a transplantable murine melanoma by vitamin A, Science 1975; 189:886-888.
15. Ratko TA, Detrisac CJ, Dinger NM, Thomas CF, Kelloff GJ, Moon RC: Chemoprcventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary' cancer in female rats, Cancer Res 1989: 49:4472-4476.
16. Fraker LD, Halter SA, Forbes JT: Effects of orally administered retinol on natural killer cell activity in wild type BALB/c and congenitally athymic BALB/c mice, Cancer Immunol Im-munother 1986:21:114-118.
17. Haenszel W, Correa P, Lopez A, Guello C, Zavala D, Fontham E: Serum micronutricnt levels in relation to gastric pathology, Int J Cancer 1985:36:43-48.
18. Sanlamaria C, Bianci A, Ravetto C: Prevention of gastric cancer induced by MNNG in rats fed supplemental carotcnoid, J Nutr Growth Cancer 1987:14:175-181.
19. Fujii T, Yokomori T: A clinical study of vitamin A concerning auxiliary chemotherapies after operation of gastric cancer, Gan To Kagaku Ryoho 1991:18:265-269.
20. Siiyu RY, Jiang SY, Huang SL, Chang TC, Wu KL, Ruffler SR, Ych MY: Regulation of growth and rctinoic acid receptor messenger ribonucleic acids expression by all-trans-retinoic acid in gastric cancer cells, Eur J Cancer 1995:31A: 237-243.
21. Sun YX, He ZP, Chen SS: Induction of differentiation of human gastric cancer cell line by retinoic acid, Chung Hua Chung Liu Tsa Chih 1994:16:15-17.
22. Tzeng C, Meng C, Jin L, Hsieh H: Cytogenetic studies of gastric adenocarcinoma, Cancer Genet Cytogenet 1991:55:67-71.
23. Labarca C, Paigen K: A simple, rapid, and sensitive DNA assay procedure, Anal Biochem 1980:102:344-352.
24. Gollardis MM, Jiang SY, Jeng MH, Jordan VC: Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens, Cancer Res 1989: 49:4090-4093.
25. SAS/STAT Users' Guide, version 6. 4th ed, Cary, SAS Institute, 1990.
26. Malkovsky M, Dore C, Hunt R, Palmer L, Chandler P, Mcdawar PB: Enhancement of specific antitumor immunity in mice fed a diet enriched in vitamin A acetate, Proc Nall Acad Sei USA 1983:80:6322-6326.
27. Villa ML, Ferrario E, Trabattoni D, Formelli F, De Palo G, Magni A, Veronesi U, Clerici E: Retinoids, breast cancer and NK cells, Br J Cancer 1993:68:845-850.
28. Lin TH, Chu TM: Enhancement of murine Ivmphokine-activatcd killer cell activity by retinoic acid, Cancer Res 1990:50:3013-3018.
29. Scgars JH, Nagata T, Bours V, Mcdin JA, Fran-zoso G, Blanco JC, Jrew PD, Becker KG, An J, Tang T, Slephany DA, Becker KG, Siebenlist U, Ozato K: Retinoic acid induction of major histocompatibility complex class I genes in NTcra-2 embryonal carcinoma cells involves induction of NF-kB (p50-p65) and retinoic acid receptor ß-rctinoid x receptor ß hetero-dimers, Mol Cell Biol 1993:13:6157-6169.
30. Meyskens FL, Goodman GE, Alberts DS: 13-cis-Retinoic acid: Pharmacology, toxicology and clinical applications for the prevention and treatment of human cancer, Crit Rev Oncol Haematol 1987;3:75-101.
31. Haq R, Pfahl M, Chytil F: Differential effects of all-trans and 13-cis-retinoic acid on mRNA levels of nuclear retinoic acid receptors in rat lung and liver, Biochem Biophys Res Commun 1991;180:1137-1144.
32. Hirschel-Scholz S, Siegenthaler G, Saurat JH: Ligand-specific and nonspecific in vivo modulation of human epidermal cellular rctinoic binding protein (CRABP), Eur J Clin Invest 1989:19:220-227.
33. Turton JA, Hicks RM, Gwvnne J, Hunt R, Hawkey CM: Retinoid toxicity; in Hugcnt J, Clark S (cds): Retinoids, Differentiation and Disease, Ciba Foundation Symposium 113. London, Pitman 1985. pp 220-251.
34. Chen TL, Feldman D: Rctinoic acid modulation of 1.25 OH>2 vitamin D-, and bioresponse in bone cells: Species differences between rat and mouse, Biochem Biophys Res Commun 1985:132:74-80.
35. Orcffo RO, Teti A, Triffitt JT, Francis MJ, Carano A, Zallone AZ, Effect of vitamin A on bone resorption: Evidence for direct stimulation of isolated chicken osteoclasts by retinol and retinoic acid, J Bone Miner Res 1988:3: 203-210.
36. Oliva A, Della Ragione F, Fratta M, Marronc G, Palumbo R, Zappia V: Effect of retinoic acid on osteocalcin gene expression in human osteoblasts, Biochem Biophys Res Commun 1993:191:908-914.
37. Schneider HG, Allan EH, Moseley JM, Martin TJ, Findlay DM: Specific down-regulation of parathyroid hormone (PTH) receptor and responses to PTH by tumour necrosis factor alpha and retinoic acid in UMR 106-06 osteo-blasl-like osteosarcoma cells, Biochem J 1991: 280:451-457.
38. McGuire J, Lawson J P: Skeletal changes associated with chronic isotretinoin and etretinate administration, Dermalologica 1987:175 (suppl 1): 169-181.
39. Saikawa Y, Kubota T, Kuo TH, Furukawa T, Kase S, Tanino H, Isobe Y, Watanabe M, Ishi-biki K, Arimori M, Kitajima M: Synergistic anlitumor activity of combination chemotherapy with mitomycin C and cisplatin against human gastric cancer xenografts in nude mice, J Surg Oncol 1994:56:242-245.
40. Pinski J, Halmos G, Yano T, Szepeshazi K, Qin Y, Ertl T, Schally AV: Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombc-sin/gastrin-rcleasing-pcptide antagonist (RC-3095) and somatostatin analogue RC-160. Int J Cancer 1994:57:574-580.
41. Upp JR Jr, Beauchamp RD, Townsend CM Jr, Barranco SC, Singh P, Rajaraman S, Janes E, Thompson JC: Inhibition of human gastric adenocarcinoma xenograft growth in nude mice by a-difluoromethylornithine, Cancer Res 1988:48:3265-3269.